Comparison of the effects of abelacimab, asundexian, and milvexian on medical device-induced clotting and thrombin generation in vitro.
- DOI
- 10.1016/j.jtha.2026.08.002
- Published
- 2026 Aug 11
- Container
- Journal of thrombosis and haemostasis : JTH
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtha.2026.08.002,
title = {Comparison of the effects of abelacimab, asundexian, and milvexian on medical device-induced clotting and thrombin generation in vitro.},
author = {Guo X and Fredenburgh JC and Weitz JI},
year = {2026},
journal = {Journal of thrombosis and haemostasis : JTH},
doi = {10.1016/j.jtha.2026.08.002},
url = {https://doi.org/10.1016/j.jtha.2026.08.002}
}RIS
TY - JOUR TI - Comparison of the effects of abelacimab, asundexian, and milvexian on medical device-induced clotting and thrombin generation in vitro. AU - Guo X AU - Fredenburgh JC AU - Weitz JI PY - 2026 JO - Journal of thrombosis and haemostasis : JTH DO - 10.1016/j.jtha.2026.08.002 UR - https://doi.org/10.1016/j.jtha.2026.08.002 ER -
APA
X, G., JC, F., & JI, W. (2026). Comparison of the effects of abelacimab, asundexian, and milvexian on medical device-induced clotting and thrombin generation in vitro.. Journal of thrombosis and haemostasis : JTH. https://doi.org/10.1016/j.jtha.2026.08.002
Source records
- pubmed · retrieved 2026-09-26T22:06:33.627Z